Treatment of Chemotherapy-Induced Thrombotic Microangiopathy with Eculizumab in a Patient with Metastatic Breast Cancer

The unexpected occurrence of thrombotic microangiopathy (TMA), characterised by microangiopathic haemolytic anaemia and thrombocytopenia, in a patient with cancer requires urgent diagnosis and appropriate management. TMA in patients with metastatic cancer can be a manifestation of the malignancy its...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Martin Hausberg, Helmut Felten, Stefan Pfeffer
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Karger Publishers 2019-01-01
coleção:	Case Reports in Oncology
Assuntos:	aHUS Atypical Haemolytic Syndrome Bevacizumab Breast cancer Complement Eculizumab Metastases Mitomycin Thrombotic microangiopathy
Acesso em linha:	https://www.karger.com/Article/FullText/495031
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!